What is the expected duration of postpartum hemorrhage (PPH) after a cesarean section (C-section)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Postpartum hemorrhage (PPH) after a cesarean section (C-section) is typically defined as a blood loss of more than 1000mL within the first 24 hours post-delivery. The expected duration of PPH can vary, but according to the World Health Organization, it is generally considered to occur within the first 24 hours after delivery 1.

Key Points to Consider

  • PPH is a major cause of maternal mortality due to obstetric hemorrhage, and its incidence is still increasing in both vaginal delivery and C-section 1.
  • The most recent and highest quality study on this topic, a network meta-analysis published in 2022, found that carbetocin is probably the most effective agent in reducing blood loss and the need for additional uterotonics after C-section 2.
  • The study also found that oxytocin appears to be more effective when initiated as a bolus, and that the combination of oxytocin and misoprostol may be inferior to oxytocin alone in reducing blood loss and the need for additional uterotonics 2.
  • Another study published in 2020 found that oxytocin used as first-line treatment of PPH probably is more effective than misoprostol with less side-effects, and that adding misoprostol to oxytocin probably makes little or no difference to effectiveness outcomes, but is associated with more side-effects 3.

Recommendations

  • Carbetocin should be considered as the first-line uterotonic agent for preventing PPH after C-section, due to its effectiveness in reducing blood loss and the need for additional uterotonics, as well as its favorable side-effect profile 2.
  • Oxytocin should be initiated as a bolus, and the combination of oxytocin and misoprostol should be used with caution due to its potential inferiority to oxytocin alone 2.
  • It is essential to monitor patients closely for signs of PPH, such as excessive bleeding, and to be prepared to administer additional uterotonics or other interventions as needed to prevent morbidity and mortality.

References

Research

[Update on the use of uterotonic agents].

Revista espanola de anestesiologia y reanimacion, 2012

Related Questions

What is the cause of profuse vaginal bleeding in a 27-year-old woman, gravida 2 para 1, at 40 weeks gestation, with a history of preeclampsia with severe features, who underwent a forceps-assisted vaginal delivery and has a firm, nontender uterus with a right vaginal sidewall defect?
What is the treatment for postpartum hemorrhage (PPH) after a cesarean section (C-section)?
What is the diagnosis for a 39-year-old primigravida (first pregnancy) at 38 weeks gestation with a history of hypertension treated with nifedipine (calcium channel blocker) and asthma treated with albuterol (beta-2 adrenergic receptor agonist), who develops postpartum hemorrhage (PPH) with a soft uterus after a forceps-assisted vaginal delivery and manual placental extraction?
What is the best medication for postpartum hemorrhage (PPH) prophylaxis besides oxytocin or methylergonovine (Methergine)?
What is the best evidence-based treatment for a prolonged second stage of labor?
What is optic neuritis (inflammation of the optic nerve)?
Is ciprofloxacin (Cipro) safe in patients with Acute Kidney Injury (AKI) stage 2, also known as Mild Impaired Renal Function?
Does terazosin (hytrin) help promote urination?
What is the expected duration of postpartum spotting after a cesarean section (C-section)?
What is the most effective Selective Serotonin Reuptake Inhibitor (SSRI) for treating mixed Irritable Bowel Syndrome (IBS)?
Is it safe to administer ceftriaxone (Ceftriaxone) to a patient with a potential penicillin (Penicillin) allergy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.